Aptima® Chlamydia trachomatis Assay
Dna Probe, Nucleic Acid Amplification, Chlamydia. 510(k) K230451, from Hologic, Inc. (San Diego, CA). Product code MKZ, class 1.
As of Nov 22, 2026, K230451 is an FDA 510(k) held by Hologic, Inc., substantially equivalent on Nov 16, 2023 after 268 days, with no recalls tied to it in FDA's recall database.
- Review time: 268 days
- Recalls: 0
The Aptima Chlamydia trachomatis (CT) assay is an in vitro qualitative nucleic acid amplification test (NAAT) for the detection of ribosomal RNA (rRNA) from Chlamydia trachomatis to aid in the diagnosis of chlamydia urogenital disease using the Panther System.
- Gen-Probe Aptima Assay for Chlamydia Trachomatis, Model 1199K063451 · Gen-Probe, Inc. · Jan 22, 2007
- Gen-Probe Aptima Assay for Chlamydia TrachomatisK043072 · Gen-Probe, Inc. · Jan 27, 2005
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 21, 2023
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3120
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files